Menin Inhibition With Revumenib for KMT2A -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).
Ghayas C IssaIbrahim AldossMichael J ThirmanJohn F DipersioMartha ArellanoJames S BlachlyGabriel N MannisAlexander E PerlDavid S DickensChristine M McMahonJennifer DunlapChristian Michel ZwaanCarolyn S GroveRichard M StonePaul J ShamiIoannis MantzarisMatthew GreenwoodNeerav N ShuklaBranko CuglievanTibor KovacsovicsYu GuRebecca G BagleyKate MadiganYakov ChudnovskyHuy Van NguyenNicole McNeerEytan M SteinPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
acute leukemia. To our knowledge, this trial represents the largest evaluation of a targeted therapy for these patients.